NeoGenomics, Inc. (NEO): Price and Financial Metrics
NeoGenomics, Inc. (NEO)
Today's Latest Price: $53.77 USD
Updated Jan 19 4:00pm
Add NEO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 64 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
NEO Stock Summary
- NEO's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 410.11 -- higher than 91.11% of US-listed equities with positive expected earnings growth.
- With a price/sales ratio of 13.78, Neogenomics Inc has a higher such ratio than 86.82% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, Neogenomics Inc is reporting a growth rate of -288.73%; that's higher than only 6.93% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Neogenomics Inc are VSAT, PRGO, THR, PEN, and QBAK.
- NEO's SEC filings can be seen here. And to visit Neogenomics Inc's official web site, go to www.neogenomics.com.
NEO Stock Price Chart Interactive Chart >
NEO Price/Volume Stats
| Current price | $53.77 | 52-week high | $57.07 |
| Prev. close | $52.78 | 52-week low | $20.47 |
| Day low | $53.11 | Volume | 1,003,500 |
| Day high | $55.25 | Avg. volume | 1,553,582 |
| 50-day MA | $49.32 | Dividend yield | N/A |
| 200-day MA | $37.75 | Market Cap | 5.97B |
NeoGenomics, Inc. (NEO) Company Bio
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company was founded in 2001 and is based in Fort Myers, Florida.
Loading social stream, please wait...